Nicholson C. David 4
4 · Allergan plc · Filed Mar 4, 2020
Insider Transaction Report
Form 4
Allergan plcAGN
Nicholson C. David
Chief R&D Officer
Transactions
- Award
Ordinary Shares, par value $0.0001
2020-03-02$193.84/sh+21,667$4,199,931→ 35,972 total
Footnotes (1)
- [F1]Includes restricted stock units issued pursuant to the Amended and Restated 2013 Incentive Award Plan of Allergan plc.